News
TKNO
6.71
-0.15%
-0.01
This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 3h ago
Alpha Teknova Price Target Announced at $8.00/Share by BTIG
Dow Jones · 4h ago
Alpha Teknova Raised to Buy From Neutral by BTIG
Dow Jones · 4h ago
BTIG Upgrades Alpha Teknova to Buy, Announces $8 Price Target
Benzinga · 4h ago
BTIG upgrades Alpha Teknova to Buy on improving fundamentals
TipRanks · 5h ago
Alpha Teknova upgraded to Buy from Neutral at BTIG
TipRanks · 5h ago
Weekly Report: what happened at TKNO last week (0803-0807)?
Weekly Report · 1d ago
Alpha Teknova price target raised to $8 from $7 at Roth Capital
TipRanks · 5d ago
Brendan Smith Initiates Buy on Teknova as Strong Q2 Results, Raised 2026 Outlook, and Emerging Biotech Tailwinds Signal Path to Scalable Profitability
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Elanco Animal Health (ELAN) and Alpha Teknova (TKNO)
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Alpha Teknova (TKNO) and Solventum Corporation (SOLV)
TipRanks · 5d ago
Alpha Teknova GAAP EPS of -$0.06 beats by $0.03, revenue of $12.2M beats by $1.29M
Seeking Alpha · 5d ago
Alpha Teknova Raises FY2026 Sales Guidance from $42.000M-$44.000M to $45.000M-$47.000M vs $43.825M Est
Benzinga · 5d ago
Alpha Teknova: Q2 Earnings Snapshot
Barchart · 6d ago
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
TipRanks · 6d ago
This Civeo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
Benzinga · 6d ago
Roth Capital Initiates Coverage On Alpha Teknova with Buy Rating, Announces Price Target of $7
Benzinga · 6d ago
Alpha Teknova initiated with a Buy at Roth Capital
TipRanks · 6d ago
Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells
Seeking Alpha · 6d ago
Weekly Report: what happened at TKNO last week (0727-0731)?
Weekly Report · 08/03 09:18
More
Webull provides a variety of real-time TKNO stock news. You can receive the latest news about Alpha Teknova through multiple platforms. This information may help you make smarter investment decisions.
About TKNO
Alpha Teknova, Inc. is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The Company offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits.